Hovione has teamed up with delivery tech developer Merrion Pharmaceuticals to provide developers of BCS class III and IV drugs with more solubility enhancement options.
Ireland’s Merrion Pharmaceuticals’ GIPET oral delivery technology platform has won the firm its second licensing agreement with Danish insulin giant Novo Nordisk.
Oral drug delivery specialists, Merrion Pharmaceuticals, have been
issued with a patent that covers new peptide compounds which can be
physically or chemically complexed with an active substance, either
a drug or a biological, in...
Merrion Pharmaceuticals has been granted a US patent for a drug
delivery technology that improves the transport of medicines across
biological membranes.
Drug delivery specialists Merrion Biopharma has announced the
opening of new facilities in Ireland, strengthening its position in
the $24 billion oral drug delivery market and reinforcing the
healthy state of the Irish pharmaceutical...